IDEAYA Biosciences, Inc. (IDYA)
38.41
-0.20
(-0.52%)
USD |
NASDAQ |
Sep 18, 16:00
38.41
0.00 (0.00%)
After-Hours: 20:00
IDEAYA Biosciences Price to Book Value : 3.088 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 3.088 |
| September 17, 2026 | 3.104 |
| September 16, 2026 | 3.033 |
| September 15, 2026 | 3.027 |
| September 14, 2026 | 3.057 |
| September 11, 2026 | 3.022 |
| September 10, 2026 | 3.010 |
| September 09, 2026 | 3.083 |
| September 08, 2026 | 3.122 |
| September 04, 2026 | 3.204 |
| September 03, 2026 | 3.213 |
| September 02, 2026 | 3.229 |
| September 01, 2026 | 3.211 |
| August 31, 2026 | 3.224 |
| August 28, 2026 | 3.224 |
| August 27, 2026 | 3.358 |
| August 26, 2026 | 3.342 |
| August 25, 2026 | 3.415 |
| August 24, 2026 | 3.219 |
| August 21, 2026 | 3.189 |
| August 20, 2026 | 3.144 |
| August 19, 2026 | 3.125 |
| August 18, 2026 | 3.049 |
| August 17, 2026 | 2.937 |
| August 14, 2026 | 2.918 |
| Date | Value |
|---|---|
| August 13, 2026 | 2.949 |
| August 12, 2026 | 2.971 |
| August 11, 2026 | 2.961 |
| August 10, 2026 | 2.953 |
| August 07, 2026 | 2.976 |
| August 06, 2026 | 2.913 |
| August 05, 2026 | 2.897 |
| August 04, 2026 | 2.903 |
| August 03, 2026 | 2.846 |
| July 31, 2026 | 2.854 |
| July 30, 2026 | 2.926 |
| July 29, 2026 | 2.861 |
| July 28, 2026 | 2.907 |
| July 27, 2026 | 2.956 |
| July 24, 2026 | 2.846 |
| July 23, 2026 | 2.912 |
| July 22, 2026 | 2.814 |
| July 21, 2026 | 2.893 |
| July 20, 2026 | 2.850 |
| July 17, 2026 | 2.895 |
| July 16, 2026 | 2.888 |
| July 15, 2026 | 2.953 |
| July 14, 2026 | 2.946 |
| July 13, 2026 | 2.906 |
| July 10, 2026 | 2.974 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Xencor, Inc. | 3.651 |
| UroGen Pharma Ltd. | -- |
| MeiraGTx Holdings Plc | 5.789 |
| ACADIA Pharmaceuticals, Inc. | 3.595 |
| Alnylam Pharmaceuticals, Inc. | 23.66 |
Price to Book Value Related Metrics
| PS Ratio | 14.73 |
| Price | 38.41 |
| Earnings Yield | -5.06% |
| Market Cap | 3.702B |